Jul 15, 2016 by Brian FeroldiWhy Ionis Pharmaceuticals Inc. Is Surging TodaySometimes no news is good news.
Jul 14, 2016 by Brian Feroldi, Keith Speights, and Cory RenauerAn Aging Population Makes These 3 Stocks Screaming BuysThe American population is getting older, which is a big reason our contributors are bullish on these three stocks.
Jul 13, 2016 by Brian FeroldiWhy Imprivata Inc. Is Soaring TodayNews that the company is being acquired by a private equity firm sent shares screaming higher.
Jul 13, 2016 by Brian Feroldi, Tyler Crowe, and Timothy Green3 Stocks We're Watching in the 3rd QuarterHere's why our team of contributors will be keeping a close watch on these three companies this quarter.
Jul 12, 2016 by Brian FeroldiWhy Shares of NetSuite Inc. Are Up Big TodayShares popped in response to rumors that the company might receive a takeover offer.
Jul 12, 2016 by Brian FeroldiHere's Why SAGE Therapeutics Inc. Is Surging TodayEncouraging data from a phase 2 study puts the markets in a good mood.
Jul 12, 2016 by Brian FeroldiInstant Analysis: Amgen's Latest Approval Raises the Bar Yet Again on Regeneron Pharmaceuticals Inc and Sanofi SA (ADR)Amgen has won FDA approval for a new device that allows for monthly dosing of its cholesterol-busting drug Repatha. Is it a game-changing innovation in its fight against Regeneron Pharmaceuticals and Sanofi?
Jul 8, 2016 by Brian Feroldi, Sean Williams, and Tyler Crowe3 Warren Buffett Stocks to Supercharge Your PortfolioWarren Buffett is a big believer in these three stocks. Perhaps you should be, too.
Jul 8, 2016 by Brian Feroldi3 Shocking Biotech Flops of 2016 So FarShareholders of these clinical-stage drugmakers have had a rotten first half. Are there any hopes for rebounds in the second half or beyond?
Jul 6, 2016 by Brian FeroldiCan Vertex Pharmaceuticals Incorporated Bounce Back From Its 28.9% Drop?It's been a tough start to the year for investors in this biopharma. What needs to happen for this company's stock to get back on track?
Jul 6, 2016 by Brian FeroldiThe Probable Reason Behind Nektar Therapeutics Inc.'s 15.5% Year-to-Date DropDespite releasing a series of positive announcements, shares still slumped. Here's why.
Jul 5, 2016 by Brian FeroldiAfter a 31% Decline, Can Shares of Ophthotech Inc. Bounce Back Later This Year?It's been a rough year for the clinical-stage biotech. Here's a look back at the key events that have contributed to the stock's decline.
Jul 4, 2016 by Brian Feroldi3 Top Healthcare Stocks to Buy NowThe market's recent jitters are creating great opportunities to buy quality companies at favorable prices.
Jul 4, 2016 by Brian FeroldiSarepta Therapeutics Inc's Stock Has Plunged 47% in 2016. Here's Why.It's been a wild year for the clinical-stage biotech.
Jul 2, 2016 by Brian Feroldi3 Healthcare Stocks That Could Raise their DividendsLooking for a dividend-paying stock that can grow its payout over time? Here are three healthcare stocks for you to consider.
Jul 1, 2016 by Brian FeroldiHere's Why Regeneron Pharmaceuticals Inc Is Down 35% This YearPositive clinical news is being overshadowed by an unfavorable court ruling and slowing growth of its core business.
Jun 30, 2016 by Brian FeroldiWhy Organovo Holdings Inc. Is Up 27% This YearShares are off to a great start to the year. Here's a recap of the key developments that have caused the stock to jump this much.
Jun 29, 2016 by Brian FeroldiShares of Tesaro, Inc. Have More Than Doubled Today. Here's WhyThe company reported great-looking data from a pivotal phase 3 trial, causing shares to skyrocket.
Jun 29, 2016 by Brian Feroldi, Daniel Miller, and Matt DiLallo3 Retirement Stocks to Buy in JulyHere's a list of three companies that are great choices for investors in their golden years.
Jun 28, 2016 by Brian FeroldiWhy Xencor Inc's Shares Are Skyrocketing TodayThe signing of a lucrative partnership agreement with a pharma giant sends shares soaring.
